View abstract

This abstract is assigned to session SBO-BOG Posters session >> in Poster area - Foyer +1

Title

Patients’ response to Travalert® evaluation

Purpose	To describe patients’ response to Travalert® in clinical practice
Methods	Travalert® is a computerized bottle holder that reminds patients to instill their drops, assists in the administration of the drop, and records the dosing time for travoprost (Travatan™) or the travoprost/timolol fixed combination (Duotrav™), (Alcon, Inc., Fort Worth, TX). Patients with ocular hypertension or any type of glaucoma treated by Travatan® or Duotrav® were recruited when attending their follow-up visit. Travalert® satisfaction questionnaire was filled in by the patients after a 4 week-period.
Results	14 patients, 11 women ; age : 35-73 years. 86% of the patients used to dose their drops themselves ; For 86% of them, dosing adherence as recorded by Travalert® was >70%. 57% found it useful and 50% easy to manipulate. The audible alarm (93%) and the visual alarm (57%) were the 2 most favoured features of the dosing. Most of the patients (93%) indicated that they were "very relieved" that the doctor was able to monitor when they dosed their medication. 43% of the patients suggested that the audible alarm should be louder. The majority (86 %) indicated that they would like to continue using Travalert®.
Conclusion	Despite the small sample of patients recruited in this study, Travalert® seemed to be well accepted and was considered an effective dosing aid and reminder by patients.

Author 1

Last name	EHONGO
Initials	A
Department	Hôpital Erasme, Université Libre de Bruxelles (ULB)
City	Bruxelles

Author 2

Last name	Heffinck
Initials	P
City	Braine-Lecompte